iFAST
Whiteley, GB · Founded 2022 · 27 employees on LinkedIn · 7 known investors
iFAST Diagnostics develops a rapid antimicrobial susceptibility testing (AST) system that uses a microfluidic impedance chip to measure the electrical properties of individual bacteria, delivering resistant/susceptible and MIC results from Gram-negative blood cultures or bacterial isolates in under three hours. The technology is aimed at hospital clinical microbiology labs and clinicians to guide antibiotic prescribing and combat antimicrobial resistance, with a focus on the UK market.
Investors · 7
Also in the syndicate · 2
Competitors · 1
by search overlap
Companies competing with iFAST for the same Google search keywords, organic and paid, via search-intersection analysis.
Companies House · registry record
View on Companies House ↗- Registered name
- IFAST UK HOLDINGS LIMITED
- Company number
- 13045848
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 26 Nov 2020
- Registered office
- 66 Lincoln's Inn Fields, London, WC2A 3LH
- Nature of business (SIC)
- 64205 — Activities of financial services holding companies
- Previous names
- EAGLES PEAK HOLDINGS LIMITED (2020–2024)
- Accounts
- last made up to 31 Dec 2024 · next due 30 Sept 2026
- Confirmation statement
- last made up to 12 Sept 2025 · next due 26 Sept 2026
Current officers · 3
- Chung Chun Lim — director, appointed 3 Oct 2022
- Vincent Tong — director, appointed 6 Jan 2022
- Wong Weiyi — director, appointed 11 Apr 2023
Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does iFAST do?
- iFAST Diagnostics develops a rapid antimicrobial susceptibility testing (AST) system that uses a microfluidic impedance chip to measure the electrical properties of individual bacteria, delivering resistant/susceptible and MIC results from Gram-negative blood cultures or bacterial isolates in under three hours. The technology is aimed at hospital clinical microbiology labs and clinicians to guide antibiotic prescribing and combat antimicrobial resistance, with a focus on the UK market.
- Who are iFAST's investors?
- iFAST's investors include Meridian Health Ventures, Cambridge Capital Group, Raw Ventures, Future Planet Capital, UK Innovation & Science Seed Fund.
- Where is iFAST headquartered?
- iFAST is headquartered in Whiteley, GB.